4//SEC Filing
SANDS ARTHUR T 4
Accession 0001209191-22-004433
CIK 0001549595other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:25 PM ET
Size
5.4 KB
Accession
0001209191-22-004433
Insider Transaction Report
Form 4
SANDS ARTHUR T
DirectorPresident, CEO
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-20+300,000→ 300,000 totalExercise: $18.89Exp: 2032-01-19→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/48 of the total shares monthly beginning February 20, 2022 until the option is fully vested on January 20, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001134106
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:25 PM ET
- Size
- 5.4 KB